Navigation Links
Memory Pharmaceuticals Receives Nasdaq Notification
Date:4/4/2008

MONTVALE, N.J., April 4, 2008 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that on April 2, 2008, it received notice from The Nasdaq Stock Market stating that the Company is no longer in compliance with the minimum $10.0 million stockholders' equity requirement for continued listing on The Nasdaq Global Market under Marketplace Rule 4450(a)(3). As reported in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, the Company's stockholders' equity was $8.3 million.

In the letter, Nasdaq staff requested that the Company provide, on or before April 17, 2008, a plan to achieve and sustain compliance with all of The Nasdaq Global Market listing requirements, including the minimum stockholders' equity requirement, and the time frame required to complete the plan. The Company is preparing its plan for submission to Nasdaq by the specified date.

If, after the conclusion of the Nasdaq staff's review process, the staff determines that the Company has not presented an appropriate definitive plan, the staff will provide the Company with a written notification that its securities will be delisted from The Nasdaq Global Market. The Company may then appeal the Nasdaq staff's delisting determination to the Nasdaq Listing Qualifications Panel.

The notification letter has no effect at this time on the continued listing of Memory Pharmaceuticals' common stock on the Nasdaq Global Market.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification
2. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
3. Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008
4. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
5. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
6. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
7. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
8. ASU researchers improve memory devices using nanotech
9. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
10. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
11. Scientists synthesize memory in yeast cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... (PRWEB) May 20, 2013 Kitware, a ... visualization tool that enables the exploration of hospital ... created in response to the recent release of “Medicare ... the top 100 most-billed procedures from the Centers for ... costs for similar procedures at hospitals across the country ...
(Date:5/20/2013)... May 20, 2013 The World Molecular ... appointment of Lisa Baird as Executive Director. Baird ... 2013. The WMIS vision is to encompass ... understand and effectively treat diseases in the developed and ... was established in 2011 by integrating the Academy of ...
(Date:5/19/2013)... MA (PRWEB) May 19, 2013 The ... social media training online, has proudly announced that the ... small business has surpassed 175,000 views on YouTube. The ... social media and SEO tips and training for small ... my students find the YouTube tips helpful for their ...
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine and Professor ... Einstein College of Medicine and Associate Chairman of the ... He is also Associate Director for Clinical Research at ... Cancer Working Group, a multidisciplinary group of physicians and ... serves as Vice Chair of the National Cancer Institute ...
Breaking Biology Technology:Kitware Enables Interactive Exploration of CMS Medicare Data 2WMIS Appoints Lisa Baird as Next Executive Director 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3
... 24 Sustainable Oils has reached a,key milestone in ... Montana farmers. The company received approval from the,Center for ... the use of camelina meal in the diets of ... of the weight of the total ration.,Camelina meal is ...
... Sept. 24 Omeros Corporation, a,Seattle-based biopharmaceutical company, ... facility with BlueCrest Capital Finance. The facility,consists of ... at closing and the,right, subject to certain conditions, ... terms were not disclosed., "This credit facility ...
... Phase 1 clinical studies support advancement to Phase 2 ... Roche polymerase inhibitors -, BRISBANE, Calif., Sept. 24 ... four abstracts from clinical and,in-vitro studies of ITMN-191 (R7227) ... American Association for the Study of Liver Diseases,(AASLD, Oct. ...
Cached Biology Technology:Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets 2Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets 3Omeros and BlueCrest Announce $20 Million Debt Facility 2InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting 2InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting 3InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting 4InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting 5InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting 6
(Date:5/20/2013)... Colo., USA New Geology articles ... May 2013 cover a wide swath of geoscience ... oceanography, geophysics, and paleobotany. Locations studied include Siberia; ... at Alpi Apuane, Italy; Ukraine; Mars; and the ... , 1. Rubies, jadeite, and plate tectonics;, 2. ...
(Date:5/19/2013)... strain of electricity-producing bacteria that can grow using hydrogen ... as its sole source of carbon. Researchers at ... the 113th General Meeting of the American Society for ... production solely on hydrogen," says Amit Kumar, a researcher ... part of the Lovley Lab Group at the university. ...
(Date:5/18/2013)... (May 19, 2013) The AGA Research Foundation is ... Damian Augustyn Award in Digestive Cancer, which will support ... Medicine at the University of Pennsylvania, Philadelphia, as he ... pancreas development, regeneration and cancer progression. , "The AGA ... honor of two distinguished clinicians and AGA Legacy Society ...
Breaking Biology News(10 mins):New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2
... maintenance, but how do skin cells know when to ... 2009 issue of the Journal of Cell Biology ... fibroblasts use a protein called PPARβ/δ to make sure ... highlight how communications between different cell types are critical ...
... with an enviable cholesterol level, working out on his treadmill. ... an abnormality in his heart,s electrical system had managed to ... is characteristic of sudden cardiac death, which annually claims more ... and lack of detectable molecules circulating in the blood makes ...
... 4 Innerscope Research(R), a revolutionary biometric media ... today the appointment of Andre Marquis as Senior ... will be responsible for expanding Innerscope,s offering into ... years experience driving innovative digital initiatives for start-ups ...
Cached Biology News:Time (and PPAR-beta/delta) heals all wounds 2Time (and PPAR-beta/delta) heals all wounds 3Hopkins scientists ID 10 genes associated with a risk factor for sudden cardiac death 2Hopkins scientists ID 10 genes associated with a risk factor for sudden cardiac death 3Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing 2
... The BV-10 offers precision ... 0.1 and 50m. The unique ... vibration free for greater control ... can be accomplished very rapidly ...
...
... Lyophilized. Lyophilized from 2 mM ... from human liver. Cathepsin D is a ... produced as a 52 kDa proenzyme. Overexpression ... is associated with higher risk of relapse ...
... highly purified preparation qualified to specifically cleave ... preparation is functionally tested for activity with ... contaminating proteases. Prepared from human plasma that ... be negative for HBsAg and for antibodies ...
Biology Products: